Table 2.
Comparison between Right Eyes with Punctate Hyperreflective Vitreous Opacities and Those Without Punctate Hyperreflective Vitreous Opacities for Ocular Characteristics Prior to Treatment
| Characteristic | No Punctate Hyperreflective Vitreous Opacities | Presence of Punctate Hyperreflective Vitreous Opacities | P-valuea |
|---|---|---|---|
| No. (%) of Right Eyes | n = 63 | n = 29 | |
| Indirect ophthalmoscopic examination findings | |||
| Diagnosis of ROP | 18 (29) | 18 (62) | 0.003 |
| Maximum stage of ROP | |||
| ROP stage 0 | 45 (71) | 11 (38) | 0.001 |
| ROP stage 1 | 9 (14) | 5 (17) | |
| ROP stage 2 | 4 (6) | 5 (17) | |
| ROP stage 3 | 5 (8) | 8 (28) | |
| Presence of pre-plus or plus disease | 3 (5) | 7 (24) | 0.005 |
| Type 1 ROP | 1 (2) | 4 (14) | 0.03 |
| Hemorrhage or vitreous haze | 2 (3) | 4 (14) | 0.12 |
| SD-OCT findings | |||
| Cystoid macular edema | 19 (30) | 10 (35) | 0.81 |
| Epiretinal membrane | 14 (22) | 13 (45) | 0.05 |
| Vitreous bands | 14 (22) | 11 (38) | 0.14 |
| Tractional subtype | 2 (3) | 3 (10) | 0.32 |
| Non-tractional subtype | 14 (22) | 9 (31) | 0.44 |
SD = standard deviation; ROP = retinopathy of prematurity; SD-OCT = spectral domain optical coherence tomography.
a
All Categorical data were analyzed by Fisher’s Exact test or Chi-Square test. Continuous data were analyzed by Non-Parametric Mann-Whitney U for two sample test.